Skip to content

Measurement of yellow fever vaccine efficacy; is 10 years the right point in time for revaccination?

Measurement of yellow fever vaccine efficacy; is 10 years the right point in time for revaccination? - YETI 10

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON39667
Enrollment
119
Registered
2013-01-07
Start date
2013-03-22
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Yellow fever infection

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: > 18 years having been administered a yellow fever vaccination

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The primary outcome measure is the proportion of volunteers who have 0.7 log10 plaque reduction, as challenge experiments have shown this to correlate with protection.

Secondary

MeasureTime frame
Another outcome measure is the proportion of volunteers who have YF-17D-specific memory, as shown by the presence of YF-17D-specific cytokine producing CD8+ and CD4+ T cells.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)